310 likes | 430 Views
FDA Marks Orphan Drug Act Milestone: 30 Year Recognition January 2013. One of Many Rare Disease Heroes…. Henry Waxman and Orrin Hatch Author and cosponsors of the Orphan Drug Act (ODA). One of Many Rare Disease Heroes…. Abbey Meyers
E N D
FDA Marks Orphan Drug Act Milestone: 30 Year Recognition January 2013
One of Many Rare Disease Heroes… Henry Waxman and Orrin Hatch Author and cosponsors of the Orphan Drug Act (ODA)
One of Many Rare Disease Heroes… Abbey Meyers Champion for ODA and founder of National Organization for Rare Disorders
One of Many Rare Disease Heroes… Media/Entertainment Industry Raising awareness about rare diseases and the need for medical products
One of Many Rare Disease Heroes… Rare Disease Advocacy Groups Organization, education, support, research, advocacy, and action
One of Many Rare Disease Heroes… FDA Orphan Incentive Programs Advancing orphan products through orphan designations, grants, and facilitation
One of Many Rare Disease Heroes… NIH Office of Rare Diseases Research Advancing rare disease information, collaboration, and research
One of Many Rare Disease Heroes… Robert Campbell Jr, MD representing Clinician/product developers and advocates; Developed the artificial rib humanitarian use device
One of Many Rare Disease Heroes… Hemin and Desiree Lyon representing 1st approved orphan designated drug and patient advocacy
One of Many Rare Disease Heroes… Jana Monaco representing Parent advocacy for newborn screening and medical foods
One of Many Rare Disease Heroes… Industry-Investors-Academia Developing products in the spirit of the ODA
One of Many Rare Disease Heroes… Sharon Terry representing Advocacy for innovative and collaborative approaches for rare disease products
One of Many Rare Disease Heroes… NIH Undiagnosed Diseases Program Cross-cutting efforts to understand and treat rare diseases
One of Many Rare Disease Heroes… Nancy Wexler, PhD representing Patient advocacy and gene discovery/research
One of Many Rare Disease Heroes… Ashley Appell representing Patients living and thriving with a rare disease
One of Many Rare Disease Heroes… FDA Offices/Centers Communication, diagnostic and therapeutic product evaluation, safety, and access
One of Many Rare Disease Heroes… Myozyme and Tiffany House representing Contributions of patient representatives to the FDA orphan approval process
One of Many Rare Disease Heroes… Ronald J. Bartek representing Family member founder of a rare disease advocacy group
One of Many Rare Disease Heroes… Pediatric Ventricular Assist Device-Berlin Heart representing ODA Grants and Humanitarian Use Devices for pediatric rare diseases
One of Many Rare Disease Heroes… Denise Ney, PhD representing Clinical dietitian/medical foods researcher for metabolic disorders
One of Many Rare Disease Heroes… Hal Dietz, MD representing Clinical research in rare diseases
One of Many Rare Disease Heroes… FDA/CDER Rare Diseases Program Focused regulatory science and education efforts for rare disease drug development
One of Many Rare Disease Heroes… NIH TRND Program Stimulating drug discovery and collaborative preclinical development for rare disease drugs
One of Many Rare Disease Heroes… EMA/EURORDIS/ IRDIRC/ICORD representing Collaborative international rare disease efforts
One of Many Rare Disease Heroes… Pearl O’Rourke, MD representing IRB efforts on behalf of rare diseases
One of Many Rare Disease Heroes… Jouni Uitto, MD, PhD representing Basic research in rare diseases
One of Many Rare Disease Heroes… George Harris Carter representing Patient advocacy for drug development and clinical trials
One of Many Rare Disease Heroes… Kalydeco representing Personalized medicines for rare diseases
One of Many Rare Disease Heroes… Leslie Boyer, MD representing Academic grantees successfully pursuing biological marketing approvals
One of Many Rare Disease Heroes… Rodney Howell, MD representing Advocacy for newborn screening/early detection and treatment of congenital disorders
FDA Marks Orphan Drug Act Milestone: 30 Year Recognition January 2013